La vendita allo scoperto per Galera Therapeutics dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Galera Therapeutics. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Galera Therapeutics (OTC:GRTX) Azioni, Report sulle vendite allo scoperto

Galera Therapeutics

Galera Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer. The Firm's lead product candidate, avasopasem manganese, is a highly selective small molecule dismutase mimetic for severe oral mucositis (SOM) in patients with head and neck cancer (HNC), the reduction of esophagitis in patients with lung cancer, and the reduction of cisplatin-induced kidney damage in patients with cancer. The Firm's second product candidate, rucosopasem manganese, has been in development to augment the anti-cancer efficacy of stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer (NSCLC) and locally advanced pancreatic cancer (LAPC).

GALERA THERAPEUTICS INC by Galera Therapeutics, Inc.

Galera Therapeutics Inc

CETX

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

CTXR

PBMWW

<a href="https://www.bloomberg.com/news/articles/2024-11-25/trump-vows-to-hit-china-mexico-canada-with-tariffs-over-border" title="https://www.bloomberg.com/news/articles/2024-11-25/trump-vows-to-hit-china-mexico-canada-with-tariffs-over-border">https://www.bloomberg.com/news/articles/2024-11-25/trump-vows-to-hit-china-mexico-canada-with-tariffs-over-border</a>
&nbsp;

Macro Economic Events

News

Politics

Economics

General

Bloomberg Reported President-Elect Trump Said Monday On His First Day In Office He Would Impose A 25% Tariff On All Products From Mexico, Canada, Plus Additional 10% Tariff On Goods From China

President-elect Donald Trump has announced plans to impose a 25% tariff on all products from Mexico and Canada in response to the ongoing border crisis, stirring economic concerns.
What Happened: Trump took to Truth Social on Monday, to express his concern over the increasing number of people crossing the borders from Mexico and Canada into the United States. He described the situation as an &#8220;invasion&#8221; and blamed it for rising crime and drug levels.
Trump stated that he would sign an executive order on the first day of his administration to impose a 25% tariff on all products entering the U.S. from Mexico and Canada. He added that the tariff would remain in effect until the drug and illegal immigration issues are resolved. &#8220;Both Mexico and Canada have the absolute right and power to easily solve this long simmering problem. We hereby demand that they use this power, and until such time that they do, it is time for them to pay a very big price!&#8221; Trump criticized China for failing to curb the flow of fentanyl into the U.S. despite promises of harsh penalties for drug dealers. He claimed the drugs, largely entering through Mexico, are at unprecedented levels, announcing a 10% tariff hike on Chinese imports, above any additional tariffs, until the issue is addressed. &#8220;Thank you for your attention to this matter,&#8221; he said in a separate post.
See Also: <a href="https://www.benzinga.com/general/health-care/24/11/42077935/trump-picks-dr-oz-who-says-seniors-should-give-medical-marijuana-a-try-to-lead-centers-for-medicare-and-medicaid-services?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Trump Picks Dr. Oz, Who Says Seniors Should Give Medical Marijuana A Try, To Lead Centers For Medicare And Medicaid Services</a>
Why It Matters: Trump&#8217;s proposed tariffs have <a href="https://www.benzinga.com/government/regulations/24/11/42058282/trumps-tariffs-could-have-severe-consequences-for-us-defense-sector-beijing-adviser-warns">raised concerns</a> among economists and industry experts. Ding Yifan, a researcher at China&#8217;s State Council's Development Research Center, warned that such tariffs could significantly impact the U.S. economy, particularly the defense sector.
Moreover, a&nbsp;<a href="https://www.benzinga.com/economics/macro-economic-events/24/11/42042411/inflation-could-surge-to-3-if-trump-applies-universal-tariffs-goldman-sachs">Goldman Sachs economist</a>&nbsp;predicted that a universal tariff could push inflation back to 3%, complicating the Federal Reserve&#8217;s efforts to keep inflation at 2%.
Renowned economist Mohamed El-Erian also <a href="https://www.benzinga.com/government/regulations/24/11/42058282/trumps-tariffs-could-have-severe-consequences-for-us-defense-sector-beijing-adviser-warns">cautioned against oversimplifying</a> Trump&#8217;s tariff strategies, emphasizing that the issue is complex and requires a nuanced analysis. While Trump&#8217;s tariff proposals are likely to hurt companies with international supply chains, others like those in the software or entertainment industry like Netflix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) that don&#8217;t sell physical products are likely to <a href="https://www.benzinga.com/trading-ideas/24/11/42144357/5-stocks-to-buy-before-tariffs-kick-in">remain protected</a> from any negative impact. Companies that have reliable production units outside China are also likely to benefit, these include names like AutoZone Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZO#NYSE">AZO</a>) and Hasbro Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAS#NASDAQ">HAS</a>).
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

NFLX

Trump Says He Will Impose 25% Tariffs On Canada, Mexico On First Day Of Office And Extra Tariffs On China Until They 'Pay Attention'

STOCK CLIMBS OVER 7% AT ITS HIGH, SIGNAL OCCURS AFTER EARLY WEAKNESS IN COIN
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="864" height="709" src="https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/25210401/Screen-Shot-2024-11-25-at-4.08.18-PM.png" alt="" class="wp-image-3606" style="width:624px" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/25210401/Screen-Shot-2024-11-25-at-4.08.18-PM.png 864w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/25210401/Screen-Shot-2024-11-25-at-4.08.18-PM-300x246.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/25210401/Screen-Shot-2024-11-25-at-4.08.18-PM-768x630.png 768w" sizes="(max-width: 864px) 100vw, 864px" /></figure>
Coinbase Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics in their trading decisions. 
Today, at 10:01 AM on November 25th, a significant trading signal occurred for Coinbase Global , Inc. as it demonstrated a Power Inflow at a price of $294.76. This indicator is crucial for traders who want to know directionally where institutions and so-called "smart money" moves in the market. They see the value of utilizing order flow analytics to guide their trading decisions. The Power Inflow points to a possible uptrend in Coinbase&#8217;s stock, marking a potential entry point for traders looking to capitalize on the expected upward movement. Traders with this signal closely watch for sustained momentum in Coinbase&#8217;s stock price, interpreting this event as a bullish sign.
Signal description
Order flow analytics, aka transaction or market flow analysis, separate and study both the retail and institutional volume rate of orders (flow). It involves analyzing the flow of buy and sell orders, along with size, timing, and other associated characteristics and patterns, to gain insights and make more informed trading decisions. This particular indicator is interpreted as a bullish signal by active traders.&nbsp;
The Power Inflow occurs within the first two hours of the market open and generally signals the trend that helps gauge the stock&#8217;s overall direction, powered by institutional activity in the stock, for the remainder of the day.&nbsp;
By incorporating order flow analytics into their trading strategies, market participants can better interpret market conditions, identify trading opportunities, and potentially improve their trading performance. But let's not forget that while watching smart money flow can provide valuable insights, it is crucial to incorporate effective risk management strategies to protect capital and mitigate potential losses. Employing a consistent and effective risk management plan helps traders navigate the uncertainties of the market in a more controlled and calculated manner, increasing the likelihood of long-term success
If you want to stay updated on the latest options trades for COIN, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.&nbsp;
<a href="https://benzinga.com/apis?_gl=1&#x2A;1hlgn5i&#x2A;_ga&#x2A;MTY1NjE2NTYxMi4xNzE0NzQ4MTAy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDc0ODEwMi4xLjEuMTcxNDc0ODQyOC4wLjAuMA..">Market News and Data brought to you by Benzinga APIs</a> and include firms, like <a href="https://finitusa.com/en/">Finit USA</a>, responsible for parts of the data within this article. 
&#xA9; 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved
After Market Close UPDATE:
The price at the time of the Power Inflow was $294.76. The returns on the High price ($317.46) and Close price ($312.30) after the Power Inflow were respectively 7.5% and 6.0%. That is why it is important to have a trading plan that includes Profit Targets and Stop Losses that reflect your risk appetite. In this case, the high of the day and close were very close but that is not always the case
Past Performance is Not Indicative of Future Results

Signals

Markets

COIN

Tradepulse Power Inflow Alert: Coinbase Global Inc. Climbs Over 20 Points After Signal

Bernard Looney, former CEO of oil and gas giant BP plc, said on Sunday he will join AI data center start-up, Prometheus Hyperscale, as the chairman of the <a href="https://www.prometheushyperscale.com/news/bernard-looney-appointed-chairman">board of directors. </a>
The Details: Looney resigned from his position at BP last year after an investigation <a href="https://www.theguardian.com/business/2023/sep/12/bp-boss-bernard-looney-to-resign-after-failing-to-reveal-ties-with-colleagues">revealed</a> he had not properly disclosed previous relationships with colleagues before becoming CEO. Looney is taking his more than 30 years of experience in the energy industry to the Wyoming-based start-up Prometheus Hyperscale.&nbsp;
Looney told the New York Times in an interview he would be helping Prometheus attract AI hyperscalers such as Microsoft and Google in need of power and space for data centers.&nbsp;
I'll be helping them with customers," he said. "I'll be helping them with investors. I'll be helping them with strategy."
Read More: <a href="https://www.benzinga.com/general/social-media/24/11/42119493/rumble-eyes-buying-bitcoin-could-it-be-the-next-microstrategy">Rumble CEO Considers Bitcoin Investment, Engages Michael Saylor As Shares Rally</a>
Prometheus plans to build a $10 billion flagship data center in Evanston, Wyoming, which will be among the largest facilities of its kind in the world when completed — the company estimates in 2025 or 2026. The company says the project encompasses a 12,000-acre ranch, including a dedicated 640-acre plot for data center facilities. 
The company secured an initial 120 MW of grid power through Rocky Mountain Power, with plans for an additional 120 MW, as well as a <a href="https://www.prometheushyperscale.com/news/oklo-partners-with-wyoming-hyperscale-to-deliver-100-megawatts-to-its-data-centers">strategic partnership</a> with Oklo Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>) a small-scale nuclear reactor company.
Prometheus signed a non-binding letter of intent with Oklo in May, outlining its intent to enter into a 20-year Power Purchase Agreement.&nbsp;
"As the widespread adoption of artificial intelligence increases, Oklo remains dedicated to providing clean, reliable and affordable energy solutions to meet the needs of our data center partners. Our partnership with Wyoming Hyperscale underscores our commitment to advancing sustainable energy practices and supporting high-efficiency operations within the data center industry," Jacob DeWitte, CEO of Oklo, said in the announcement in May.&nbsp;
Combining the partnership with Oklo and its plans for incorporating a mix of wind, solar and gas power sources, Prometheus has an on-site generation goal of over 1 GW.&nbsp;
Looney said in the interview that he aims to help Prometheus Hyperscale address what he called downsides of A.I., including potential in emissions.&nbsp;
"We have to work on that," he said.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/24/11/41949068/bitcoin-could-reach-1-million-by-2037-economist-says-buy-of-a-lifetime-opportunity">Bitcoin Could Reach $1 Million By 2037, Economist Says: &#8216;Buy Of A Lifetime&#8217; Opportunity</a></li>
</ul>
Photo: Courtesy of Prometheus Hyperscale

Management

Tech

OKLO

Former BP Oil CEO Joins AI Data Center Startup Prometheus Hyperscale

Scotiabank analyst Nicholas Yulico maintains Welltower (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WELL#NYSE">WELL</a>) with a Sector Outperform and raises the price target from $133 to $142.

Price Target

Analyst Ratings

WELL

Scotiabank Maintains Sector Outperform on Welltower, Raises Price Target to $142

Scotiabank analyst Tanya Jakusconek maintains Barrick Gold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOLD#NYSE">GOLD</a>) with a Sector Outperform and lowers the price target from $24 to $23.

GOLD

Scotiabank Maintains Sector Outperform on Barrick Gold, Lowers Price Target to $23

Scotiabank analyst Greg Harrison maintains BridgeBio Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBIO#NASDAQ">BBIO</a>) with a Sector Outperform and raises the price target from $45 to $48.

BBIO

Scotiabank Maintains Sector Outperform on BridgeBio Pharma, Raises Price Target to $48

Scotiabank analyst Eric Winmill maintains Gold Royalty (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GROY#AMEX">GROY</a>) with a Sector Outperform and lowers the price target from $2.5 to $2.25.

GROY

Scotiabank Maintains Sector Outperform on Gold Royalty, Lowers Price Target to $2.25

Scotiabank analyst Ben Isaacson maintains Sociedad Quimica Y Minera (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQM#NYSE">SQM</a>) with a Sector Outperform and lowers the price target from $60 to $50.

Scotiabank Maintains Sector Outperform on Sociedad Quimica Y Minera, Lowers Price Target to $50

Formula 1 is expanding with an 11th team joining the global motorsport for the 2026 season, naming General Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) <a href="https://www.benzinga.com/24/11/42135392/general-motors-gears-up-for-potential-f1-entry-in-2026-report">with Andretti Global.</a>
While the new team is still over a year away from starting, it will add an increased American presence to the sport and more competition for recent and four-time consecutive champion <a href="https://www.benzinga.com/general/education/21/12/24561188/max-verstappen-claims-his-first-f1-world-championship-5-things-you-might-not-know-about-the-for">Max Verstappen.</a>
What Happened: Formula 1, which is a unit of publicly traded Liberty Formula One (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWONA#NASDAQ">FWONA</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWONK#NASDAQ">FWONK</a>), announced it reached an agreement with General Motors for a new team, branded as Cadillac, which will enter beginning in 2026, following up a previous rejection of a GM-linked team <a href="https://www.benzinga.com/general/entertainment/24/01/36875148/formula-one-rejects-andretti-general-motors-team-bid-what-this-could-mean-for-us-growth-esp">earlier this year.</a>
General Motors will also become an engine supplier for the league at a later date, the league <a href="https://www.formula1.com/en/latest/article/statement-on-general-motors-application-to-join-fia-formula-one-world.69uoRF1uwHwXkr4efkpnhc">announced</a>. The GM team will use Ferrari engines until the GM engines are officially approved for the sport.
"With Formula 1's continued growth plans in the U.S., we have always believed that welcoming an impressive U.S. brand like GM/Cadillac to the grid and GM as a future power unit supplier could bring additional value and interest to the sport," Liberty Media CEO Greg Maffei said.
General Motors President Mark Reuss called Formula 1 the "pinnacle of motorsports" and said the announcement of becoming the 11th team is an honor for the automotive company.
"We're committed to competing with passion and integrity to elevate the sport for race fans around the world," Reuss said. "This is a global stage for us to demonstrate GM's engineering expertise and technology leadership at an entirely new level."
The approval of the team comes after the U.S. Justice Department launched an investigation into why Liberty Media, who owns the commercial rights to Formula 1, would not approve the American team bid started by Michael Andretti.
The new team, called Cadillac F1, will be run by Andretti Global majority owners Dan Towriss and Mark Walter after Andretti stepped aside from the group in September. Former Formula 1 champion and racing legend Mario Andretti will have an ambassador role with Cadillac F1 while his son Michael will have no official position.
Read Also: <a href="https://www.benzinga.com/general/entertainment/23/12/36222143/netflix-lands-more-live-sports-how-success-of-docuseries-helped-pave-the-way">Netflix Lands More Live Sports: How Success Of Docuseries Helped Pave The Way</a>
Why It's Important: The announcement comes after Formula 1's Las Vegas Grand Prix, one of three U.S. races in 2024, was recently held and saw Max Verstappen <a href="https://www.espn.com/f1/story/_/id/42520866/max-verstappen-wins-fourth-f1-world-title-las-vegas-red-bull">win </a>his fourth consecutive Formula 1 World Championship.
While Verstappen finished fifth in the race, he secured enough points to guarantee that no one could match his points total with two races left in the season. This marks the fourth consecutive title by Verstappen with his first title in 2021 a close one with<a href="https://www.benzinga.com/general/sports/24/02/36897433/f1-legend-lewis-hamilton-set-to-join-ferrari-likely-to-replace-sainz-in-major-team-shake-up"> racing legend Lewis Hamilton.</a>
Verstappen has been dominant in the sport in recent years winning the title with races still left in season three of the four years. Verstappen won seven of the first 10 races this season before falling out of form but later did enough to win enough points to secure the title.
The new GM team marks the second American-owned team. Gene Haas owns a team but chooses to have international drivers. Michael Andretti's original vision was to have an American-owned team and also feature American drivers, something that fans of the sport will be closely watching.
Team expansion has been infrequent with four teams added in 2010 to push the total to 13 teams and 26 cars. Of the four teams added, one never raced and the other three were out of the league by 2017, as <a href="https://apnews.com/article/f1-grid-expansion-11th-team-andretti-9ffab2a3b1c71d59bd838b1c154b690f?taid=6744c0a5988d9800014d4a8b&amp;utm_campaign=TrueAnthem&amp;utm_medium=AP&amp;utm_source=Twitter">reported </a>by the Associated Press. &nbsp;
The existing 10 team owners have been against expansion due to the dilution of prize money, but have no formal say in the approval process.
Adding another American team could benefit ESPN, which is a unit of Walt Disney Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>). ESPN secured the renewal of the U.S. rights in 2022, paying an estimated $75 million to $90 million annually for the rights for three additional years.
ESPN fought off several other parties interested in the rights, as viewership for the sport has surged in recent years.
Along with recent growth in viewership in the U.S. Formula One teams have also experienced increased interest in ownership stakes from investors, including several notable American football players.
The Alpine racing team received&nbsp;<a href="https://www.formula1.com/en/latest/article.patrick-mahomes-travis-kelce-anthony-joshua-and-rory-mcilroy-among-host-of.3J4ua82zLZnEDJuM5Cegpe.html" target="_blank" rel="noreferrer noopener">investments&nbsp;</a>in 2023 from Kansas City Chiefs players&nbsp;Patrick Mahomes&nbsp;and&nbsp;Travis Kelce, professional golfer&nbsp;Rory McIlroy&nbsp;and actor&nbsp;Ryan Reynolds.
FWONA Price Action: Liberty Formula One shares were up 4.25% to $80.74 on Monday, hitting an intraday high of $80.88, which is a new 52-week high. The stock is up 41% year-to-date in 2024.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/24/09/41099414/ryan-reynolds-has-built-multiple-billion-dollar-brands-will-marketing-company-named-after-d">Ryan Reynolds&#8217; Billion-Dollar Streak: Will His Viral Marketing Firm Go Public Next?</a></li>
</ul>
Photo: Jay Hirano Photography via Shutterstock

Sports

Movers

Trading Ideas

FWONA

FWONK

Formula 1 Stock Hits 52-Week High, Announces 11th Team With General Motors/Andretti Global After Max Verstappen's Fourth Straight Title

SNBR

Sleep Number Issues Response To Public Letter To Shareholders From Stadium Capital Management; Reiterates That Its Highest Priority Is Identifying And Recruiting Optimal CEO Candidate

Scotiabank analyst Meny Grauman maintains Bank of Montreal (TSX:<a class="ticker" href="https://www.benzinga.com/stock/BMO#TSX">BMO</a>) with a Sector Outperform and raises the price target from C$112 to C$147.

TSX:BMO

Scotiabank Maintains Sector Outperform on Bank of Montreal, Raises Price Target to C$147

The Company expects the Restated Financial Statements to reflect the following approximate impacts: as of December 31, 2023, (i) an increase in assets of $190 million, (ii) an increase in accrued expenses and other liabilities of $783 million, and (iii) a decrease in retained earnings of $593 million.&nbsp;
For the years ended December 31, 2023 and 2022, pre-tax income would be reduced by approximately $190 million to $3,636 million and $77 million to $5,641 million, respectively. For the third quarter of 2024, pre-tax income would decrease by approximately $6 million to $1,282 million while pre-tax income for the nine months ended September 30, 2024 would increase by approximately $700 million to $4,462 million (as compared to the pre-tax income reported in the financial information with respect to the quarter ended September 30, 2024 in the exhibits furnished with the Company's Current Report on Form 8-K filed with the SEC on October 16, 2024).

Discover Financial Services Gets NYSE Notice Regarding Filing Of Form 10-Q; Plans To Restate Certain Prior Period Financial Statements

Scotiabank analyst Meny Grauman maintains Canadian Imperial Bank (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CM#TSX">CM</a>) with a Sector Outperform and raises the price target from C$85 to C$108.

TSX:CM

Scotiabank Maintains Sector Outperform on Canadian Imperial Bank, Raises Price Target to C$108

Guidance

LexinFintech Says Cautious About Short-term Economic Outlook And Anticipate Recently Released Government Stimulus Measures Targeting Economic Recovery To Gradually Take Effect

Galera Therapeutics GAAP EPS of -$0.10

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to dive into the biggest pre-market stock movers with all of the hottest news worth reading about on Wednesday!



Moving stocks this morning are earnings reports, acquisition plans, new drug data and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>INVO Bioscience (NASDAQ:<a href="https://investorplace.com/stock-quotes/invo-stock-quote/">INVO</a>) stock is rocketing more than 55% alongside its <a href="https://finance.yahoo.com/news/invo-reports-fourth-quarter-full-205900118.html">Q4 earnings report</a>.</li>



<li>Vanda Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/vnda-stock-quote/">VNDA</a>) shares are soaring over 38% on <a href="https://www.nasdaq.com/press-release/future-pak-confirms-proposal-to-acquire-vanda-pharmaceuticals-for-%247.25-to-%247.75-per">a firm acquisition proposal</a>.</li>



<li>VIA Optronics (NYSE:<a href="https://investorplace.com/stock-quotes/viao-stock-quote/">VIAO</a>) stock is surging more than 32% with heavy pre-market trading.</li>



<li>Clene (NASDAQ:<a href="https://investorplace.com/stock-quotes/clnn-stock-quote/">CLNN</a>) shares are rising over 26% on <a href="https://seekingalpha.com/news/4090283-clene-stock-rallies-post-market-on-ms-drug-data?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain%7Csection%3Aon-the-move">new drug data</a>.</li>



<li>Chromocell Therapeutics (NYSEMKT:<a href="https://investorplace.com/stock-quotes/chro-stock-quote/">CHRO</a>) stock is gaining more than 26% on an update to a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318239123&amp;type=PDF&amp;symbol=CHRO&amp;cdn=722216dc7f57070dff83767fe9648f9d&amp;companyName=Chromocell+Therapeutics+Corporation&amp;formType=424B3&amp;formDescription=Prospectus+%5BRule+424%28b%29%283%29%5D&amp;dateFiled=2024-04-17">secondary stock offering</a>.</li>



<li>CXApp (NASDAQ:<a href="https://investorplace.com/stock-quotes/cxai-stock-quote/">CXAI</a>) shares are increasing over 26% with its <a href="https://www.marketwatch.com/story/cxapp-shares-rise-29-on-4q-2023-annual-recurring-revenue-growth-13f8abea">latest earnings report</a>.</li>



<li>Seelos Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/seel-stock-quote/">SEEL</a>) stock is climbing more than 24% without any clear news on Wednesday morning.</li>



<li>Mobile Global Esports (NASDAQ:<a href="https://investorplace.com/stock-quotes/mgam-stock-quote/">MGAM</a>) shares are getting a 22% boost as it <a href="https://investorplace.com/2024/04/why-is-mobile-global-esports-mgam-stock-down-18-today/">prepares for delisting</a>.</li>



<li>Gamer Pakistan (NASDAQ:<a href="https://investorplace.com/stock-quotes/gpak-stock-quote/">GPAK</a>) stock is jumping 21% despite a lack of news today.</li>



<li>Galera Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/grtx-stock-quote/">GRTX</a>) shares are up over 19% on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318238318&amp;type=PDF&amp;symbol=GRTX&amp;cdn=6788b7c94daccbdc9a6c5412e270d44c&amp;companyName=Galera+Therapeutics+Inc.&amp;formType=SC+13G&amp;formDescription=Statement+of+acquisition+of+beneficial+ownership+by+individuals&amp;dateFiled=2024-04-16">shareholder stake update</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Trilogy Metals (NYSEMKT:<a href="https://investorplace.com/stock-quotes/tmq-stock-quote/">TMQ</a>) stock is plummeting more than 22% <a href="https://www.nasdaq.com/press-release/trilogy-metals-provides-update-on-the-ambler-access-project-2024-04-17">following an update</a> to its Ambler Access Project.</li>



<li>Trio Petroleum (NYSEMKT:<a href="https://investorplace.com/stock-quotes/tpet-stock-quote/">TPET</a>) shares are diving over 20% after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318239194&amp;type=PDF&amp;symbol=TPET&amp;cdn=fb7a5495a316777660288b1087458323&amp;companyName=Trio+Petroleum+Corp.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-04-17">securing senior notes and a purchase agreement</a>.</li>



<li>Connexa Sports Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/yyai-stock-quote/">YYAI</a>) stock is tumbling more than 18% on Wednesday morning.</li>



<li>Destiny Tech100 (NYSE:<a href="https://investorplace.com/stock-quotes/dxyz-stock-quote/">DXYZ</a>) shares are taking a close to 18% beating following a rally yesterday.</li>



<li>Ontrak (NASDAQ:<a href="https://investorplace.com/stock-quotes/otrk-stock-quote/">OTRK</a>) stock is sliding over 16% with the release of its <a href="https://finance.yahoo.com/news/ontrak-announces-2023-fourth-quarter-200500612.html">Q4 2023 earnings report</a>.</li>



<li>Dragonfly Energy (NASDAQ:<a href="https://investorplace.com/stock-quotes/dfli-stock-quote/">DFLI</a>) shares are retreating more than 16% <a href="https://investorplace.com/2024/04/why-is-dragonfly-energy-dfli-stock-up-56-today/">after rallying yesterday</a>.</li>



<li>Dynatronics (NASDAQ:<a href="https://investorplace.com/stock-quotes/dynt-stock-quote/">DYNT</a>) stock is pulling back over 16% <a href="https://investorplace.com/2024/04/why-is-dynatronics-dynt-stock-up-93-today/">after rising on Tuesday</a>.</li>



<li>Ryvyl (NASDAQ:<a href="https://investorplace.com/stock-quotes/rvyl-stock-quote/">RVYL</a>) shares are still falling more than 15% despite <a href="https://www.nasdaq.com/press-release/ryvyl-inc.-announces-cancellation-of-proposed-underwritten-public-offering-2024-04-16">canceling a proposed public offering</a>.</li>



<li>Hub Cyber Security (NASDAQ:<a href="https://investorplace.com/stock-quotes/hubc-stock-quote/">HUBC</a>) stock is dropping over 14% <a href="https://investorplace.com/2024/04/why-is-hub-cyber-security-hubc-stock-up-35-today/">after a rally yesterday</a>.</li>



<li>iSun (NASDAQ:<a href="https://investorplace.com/stock-quotes/isun-stock-quote/">ISUN</a>) shares close out our pre-market stock movers down more than 13% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318238741&amp;type=PDF&amp;symbol=ISUN&amp;cdn=82f25393dbc89b776256155c3f0856b7&amp;companyName=iSun+Inc.&amp;formType=10-K&amp;formDescription=Annual+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-04-16">on an investor update</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-april-17th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to start off the trading week with a look at the biggest pre-market stock movers for Monday morning!



Moving stocks this morning are earnings, investments, a delisting and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Moolec Science (NASDAQ:<a href="https://investorplace.com/stock-quotes/mlec-stock-quote/">MLEC</a>) stock is rocketing more than 67% on approval for its <a href="https://www.nasdaq.com/press-release/moolec-becomes-first-molecular-farming-company-to-achieve-usda-approval-for-plant">plant-groan animal proteins</a>.</li>



<li>OLB Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/olb-stock-quote/">OLB</a>) shares are soaring over 46% with heavy pre-market trading.</li>



<li>Complete Solaria (NASDAQ:<a href="https://investorplace.com/stock-quotes/cslr-stock-quote/">CSLR</a>) stock is surging more than 42% <a href="https://www.nasdaq.com/press-release/retail-stock-sector-and-chairman-t.j.-rodgers-invest-in-complete-solaria-2024-04-21">on investment news</a>.</li>



<li>SuperCom (NASDAQ:<a href="https://investorplace.com/stock-quotes/spcb-stock-quote/">SPCB</a>) shares are gaining over 33% ahead of its <a href="https://www.nasdaq.com/press-release/supercom-to-report-fourth-quarter-and-full-year-2023-financial-results-on-april-22">Q4 2023 earnings report</a> this morning.</li>



<li>Dermata Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/drma-stock-quote/">DRMA</a>) stock is rising more than 18% on Monday morning.</li>



<li>Galera Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/grtx-stock-quote/">GRTX</a>) shares are increasing over 17% without any clear news this morning.</li>



<li>Palisade Bio (NASDAQ:<a href="https://investorplace.com/stock-quotes/pali-stock-quote/">PALI</a>) stock is climbing more than 16% despite a lack of news today.</li>



<li>Global Gas (NASDAQ:<a href="https://investorplace.com/stock-quotes/hgas-stock-quote/">HGAS</a>) shares are heading over 14% higher on Monday.</li>



<li>Volato (NYSEMKT:<a href="https://investorplace.com/stock-quotes/soar-stock-quote/">SOAR</a>) stock is jumping more than 13% on Monday morning.</li>



<li>Portage Biotech (NASDAQ:<a href="https://investorplace.com/stock-quotes/prtg-stock-quote/">PRTG</a>) shares are up over 13% today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Vaxxinity (NASDAQ:<a href="https://investorplace.com/stock-quotes/vaxx-stock-quote/">VAXX</a>) stock is crashing more than 55% on the company&rsquo;s <a href="https://finance.yahoo.com/news/vaxxinity-announces-intention-voluntarily-delist-202700884.html">plans to delist its shares</a>.</li>



<li>EzFill (NASDAQ:<a href="https://investorplace.com/stock-quotes/ezfl-stock-quote/">EZFL</a>) shares are plummeting close to 37% this morning.</li>



<li>Hepion Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/hepa-stock-quote/">HEPA</a>) stock is diving over 29% on plans to <a href="https://www.nasdaq.com/press-release/hepion-pharmaceuticals-initiates-wind-down-activities-in-phase-2b-ascend-nash-trial">wind down a clinical trial</a>.</li>



<li>iLearningEngines (NASDAQ:<a href="https://investorplace.com/stock-quotes/aile-stock-quote/">AILE</a>) shares are tumbling more than 21% after <a href="https://finance.yahoo.com/news/ilearningengines-inc-becomes-publicly-traded-200500132.html">going public last week</a>.</li>



<li>Redwoods Acquisition (NASDAQ:<a href="https://investorplace.com/stock-quotes/rwod-stock-quote/">RWOD</a>) stock is taking an over 15% beating <a href="https://investorplace.com/2024/04/why-is-redwoods-acquisition-rwod-stock-up-72-today/">after a recent rally</a>.</li>



<li>Biophytis (NASDAQ:<a href="https://investorplace.com/stock-quotes/bpts-stock-quote/">BPTS</a>) shares are sliding more than 15% ahead of <a href="https://www.nasdaq.com/press-release/biophytis-announces-ratio-change-under-its-american-depositary-receipt-adr-program-0">a ratio change tomorrow</a>.</li>



<li>Adlai Nortye (NASDAQ:<a href="https://investorplace.com/stock-quotes/anl-stock-quote/">ANL</a>) stock is dropping nearly 15% today.</li>



<li>BioSig Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/bsgm-stock-quote/">BSGM</a>) shares are falling over 13% this morning.</li>



<li>Sunshine Biopharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/sbfm-stock-quote/">SBFM</a>) stock is decreasing more than 12% today.</li>



<li>Indonesia Energy (NYSEMKT:<a href="https://investorplace.com/stock-quotes/indo-stock-quote/">INDO</a>) shares close out our pre-market stock movers down over 10%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-april-22nd/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Galera Therapeutics (GRTX) has issued an update. Galera Therapeutics, Inc. has implemented a stockholder rights plan, issuing one Right per common ...

Galera Therapeutics Enacts Plan to Deter Hostile Takeovers

Galera Therapeutics GAAP EPS of -$0.08

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Galera Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/grtx-stock-quote/">GRTX</a>) just reported results for the first quarter of 2024.<ul><li>Galera Therapeutics reported earnings per share of -8 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/grtx-stock-earnings-galera-therapeutics-for-q1-of-2024/">GRTX Stock Earnings: Galera Therapeutics Reported Results for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

GRTX Stock Earnings: Galera Therapeutics Reported Results for Q1 2024

Galera Therapeutics (GRTX) has provided an update. Galera Therapeutics, Inc. is streamlining its operations amidst a strategic review by eliminatin...

Galera Therapeutics Restructures Leadership and Cuts Costs

Galera Therapeutics (GRTX) just unveiled an announcement. Galera Therapeutics, Inc. recently settled a lawsuit against two Clinical Research Organi...

Galera Therapeutics Settles Clinical Trial Dispute Lawsuit

Galera Therapeutics (GRTX) has shared an update. Galera is set to dissolve and wind up its business, a decision made by the Board to benefit the sh...

Galera Therapeutics Announces Wind-Up and Special Stockholder Meeting

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Galera Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/grtx-stock-quote/">GRTX</a>) just reported results for the second quarter of 2024.<ul><li>Galera Therapeutics reported earnings per share of -7 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/grtx-stock-earnings-galera-therapeutics-for-q2-of-2024/">GRTX Stock Earnings: Galera Therapeutics Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

GRTX Stock Earnings: Galera Therapeutics Reported Results for Q2 2024

AILE

BPTS

BSGM

CHRO

CLNN

CSLR

CXAI

DFLI

DRMA

DXYZ

DYNT

EZFL

GPAK

GRTX

HEPA

HGAS

HUBC

INDO

INVO

ISUN

MGAM

MLEC

OTRK

PALI

PRTG

RVYL

RWOD

SBFM

SEEL

SOAR

SPCB

TPET

VAXX

VIAO

VNDA

YYAI

Biotech

Earnings

Press Releases

Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates

Galera Adopts Limited Duration Stockholder Rights Agreement

Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates

Comments

Galera Therapeutics

Vendite allo scoperto

Galera Therapeutics (OTC:GRTX) Azioni, Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO